Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Sabine Venne-Dunker has worked on the following 16 EPO patent applications which have been published in the last five years:

EP11757858

SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

IPC classification:
A61K 31/437, A61K 31/439, A61P 9/06, C07D 471/04, C07D 471/18
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757271

INDANYL-SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

IPC classification:
A61K 31/4353, A61P 9/06, A61P 25/28, C07D 471/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759725

N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4985, A61P 19/02, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP12794728

CRYSTALLINE FORMS OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE

IPC classification:
A61K 31/506, A61P 29/00, C07D 403/14
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP12806043

ISOTHIAZOLOPYRIDINE-2-CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4745, A61K 31/496, A61K 31/498, A61K 31/53, A61K 31/5377, A61P 19/00, A61P 25/00, A61P 35/00, C07D 513/00, C07D 513/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13702225

FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/429, A61K 31/437, A61K 31/5365, A61K 31/5383, A61K 31/542, A61P 9/06, A61P 11/00, C07D 471/04, C07D 498/04, C07D 513/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13723767

BENZO[1,3]DIOXINE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS

IPC classification:
A61K 31/357, A61K 31/4025, A61K 31/41, A61K 31/4433, A61P 9/00, C07D 319/08, C07D 401/04, C07D 401/12, C07D 403/04, C07D 403/12, C07D 413/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP13723150

PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH PATHOLOGICAL THROMBUS FORMATION

IPC classification:
A61K 31/4418, A61P 7/02, C07D 213/30
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP13723151

PYRAZOLE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS

IPC classification:
A61K 31/415, A61K 31/4155, A61P 7/02, C07D 231/12, C07D 409/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14711467

N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/437, A61K 31/52, A61P 9/00, A61P 19/02, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP11743050

PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES

IPC classification:
C07D 213/74, C07D 239/42
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11715496

TRICYCLIC PYRIDYL-VINYL-PYROLES AS PAR1 INHIBITORS

IPC classification:
A61K 31/407, A61K 31/437, A61K 31/4985, A61K 31/5383, A61P 7/02, C07D 471/14, C07D 487/14, C07D 498/14
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11714317

Pyridyl-vinyl-pyrazolo-chinolines as PAR1 inhibitors

IPC classification:
A61K 31/444, A61P 9/00, C07D 471/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14729285

MACROCYCLIC UREA DERIVATIVES AS INHIBITORS OF TAFI A, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/553, A61P 7/00, C07D 273/01, C07D 413/12
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
The patent has been granted
EP11737951

CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION

IPC classification:
A61K 38/12, C07K 7/50
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP15731617

2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS

IPC classification:
A61K 31/506, A61P 19/02
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature